Ultragenyx Pharma (RARE) PT Lowered to $63 at Jefferies
Tweet Send to a Friend
Jefferies analyst Maury Raycroft lowered the price target on Ultragenyx Pharma (NASDAQ: RARE) to $63.00 (from $114.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
